Maternal immunisation
By Emmanuel Hanon, Senior Vice President, Head of Vaccines Research & Development, GSK
Vaccine Technology
Content related to Vaccine Technology:
Calixar and VirPath develop an innovative manufacturing process for high performance influenza vaccines
By Andrew Lloyd & Associates
Excipient selection in biologics and vaccines formulation development
By M. Babu Medi and Ramesh Chintala, Vaccine Drug Product Development, Merck & Co, Inc and Akhilesh Bhambhani, Novel Adjuvants, Formulation and Delivery Technologies, Merck & Co, Inc.
Development of stabilised vaccines with needle-free devices for targeted skin immunisation
By Abina M. Crean & Anne C. Moore, School of Pharmacy, University College Cork and Conor O’Mahony, Tyndall National Institute, University College Cork
Maintaining vaccine security
By Howard Smith, Technical and Commercial Manager, Cambridge Biostability
Follow: